Moreover, inactivation of p53 was insufficient to allow untransformed B cells and B cell lymphomas to survive without Dicer [68], providing further support that at least in B cell malignancies interaction of p53 with DICER plays critical role in cell survival and drug response. This evidence concerns the gene TP53 and B-cell non-Hodgkin lymphoma.